phenyl acetate has been researched along with Vascular Calcification in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godugu, K; Mason, DL; Mousa, SA; Nnani, D | 1 |
| Behets, GJ; D'Haese, PC; De Schutter, TM; Geryl, H; Gundlach, K; Neven, E; Passlick-Deetjen, J; Peter, ME; Steppan, S | 1 |
| Behets, GJ; Büchel, J; D'Haese, PC; Dams, G; De Schutter, TM; Gundlach, K; Neven, E; Passlick-Deetjen, J; Steppan, S | 1 |
| Bondor, C; Brumboiu, A; Gherman-Caprioara, M; Kacso, I; Moldovan, D; Moldovan, I; Orasan, R; Parvu, L; Patiu, IM; Racasan, S; Rusu, C | 1 |
| Allison, MA; Asplin, J; Block, GA; Chertow, GM; Hoofnagle, AN; Kestenbaum, B; Ketteler, M; Kooienga, L; Mannstadt, M; Persky, MS; Smits, G; Spiegel, DM; Thadhani, R; Wheeler, DC; Wolf, M | 1 |
1 trial(s) available for phenyl acetate and Vascular Calcification
| Article | Year |
|---|---|
Effects of phosphate binders in moderate CKD.
Topics: Acetates; Aged; Aged, 80 and over; Bone Density; Calcium Compounds; Chelating Agents; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pilot Projects; Polyamines; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2012 |
4 other study(ies) available for phenyl acetate and Vascular Calcification
| Article | Year |
|---|---|
Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease.
Topics: Acetates; Calcium; Calcium Compounds; Chelating Agents; Humans; Inflammation; Polyamines; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2022 |
Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
Topics: Acetates; Adenine; Animals; Aortic Diseases; Bone Morphogenetic Protein 2; Calcium; Calcium Compounds; Calcium-Binding Proteins; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Gene Expression Regulation; Hyperphosphatemia; Kidney Failure, Chronic; Magnesium; Male; Matrix Gla Protein; Parathyroid Hormone; Phosphates; Polyamines; Rats; Rats, Wistar; Sevelamer; SOX9 Transcription Factor; Time Factors; Uremia; Vascular Calcification | 2013 |
A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats.
Topics: Acetates; Animals; Biomarkers; Bone and Bones; Bone Remodeling; Calcium Compounds; Diet; Disease Models, Animal; Kidney Failure, Chronic; Magnesium; Male; Phosphates; Phosphorus; Rats; Vascular Calcification | 2014 |
Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them?
Topics: Acetates; Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Radiography; Renal Dialysis; Risk Factors; Serum Albumin; Sex Factors; Vascular Calcification | 2011 |